Amino acid sequences of cytotoxin-like basic proteins derived from cobra venoms. 1989

S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
Department of Biochemistry, Osaka University of Pharmaceutical Sciences, Japan.

Amino acid sequences of cytotoxin-like basic proteins (CLBPs), purified from the venoms of Formosan cobra (Naja naja atra) and Indian cobra (Naja naja), were reinvestigated. The determined sequences differed from those reported previously by Takechi et al. [(1985) Biochem. Int. 11, 795-802; (1987) Biochem. Int. 14, 145-152]. The sequence of CLBPs at residues 25-30 was found to be hydrophilic as compared with those of cytotoxins. The difference in the hydrophobicity of this region might be responsible for the difference in their cytotoxic activities.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D005075 Biological Evolution The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics. Evolution, Biological
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
February 1991, FEBS letters,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
June 1971, Die Naturwissenschaften,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
June 1972, Japanese journal of medical science & biology,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
June 1987, FEBS letters,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
February 1990, FEBS letters,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
July 1995, International journal of peptide and protein research,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
December 1971, Biochemical and biophysical research communications,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
January 2004, Protein engineering, design & selection : PEDS,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
January 1966, Experientia,
S Inoue, and K Okumura, and M Tsujino, and K Ohkura, and K Ikeda, and M Takechi, and Y Tanaka, and K Hayashi
July 1972, Molecular pharmacology,
Copied contents to your clipboard!